Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Liraglutide Effect and Action in Diabetes (LEAD-5): Effects on glycaemic control after once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and metformin combination therapy, and versus insulin glargine added to glimepiride and metformin combination therapy in subjects with type 2 diabetes. A six-month randomised, double-blind, parallel-group, multi-centre, multi-national trial with an open-label treat-to-target insulin glargine control arm https://kusajili.fr:443/Trial/IBO0S5jBVky6Iq8U_FC-Cg%24liraglutide-effect-and-action-in-diabetes-lead-5-effects-on-glycaemic-control-after-once-daily-administration-of-liraglutide-in
I have read and accept the terms of use of the site and the Privacy Policy
Send your message